What NeuroLacto.AI Has Already Achieved

Version 1, completed

NeuroLacto.AI has successfully completed its first operational phase. Ver1.0 completed, and it can record and analyse infant sucking behaviour, process feeding signals, and categorize infants into clinically useful groups in below:

Normal: Effective feeding pattern

Borderline: Mild concern requiring observation

At Risk: Moderate concern requiring follow-up

High Risk: Significant concern requiring urgent attention

This means the platform is already capable of delivering a real-world service: early sucking screening with automated reporting. The immediate value of Version 1 includes:

Objective support for early feeding assessment
Faster identification of newborns who need attention
Better guidance opportunities for families
Creation of structured digital reports
Foundation data for future AI versions

Version 1 is therefore ready for supervised pilot implementation.

Author:

Navid Nasiri, 29.04.2026

What Comes Next: Versions 2 to 4

The long-term strength of NeuroLacto.AI is that Version 1 is only the beginning. Once implemented in hospitals, the system can ethically collect structured anonymized follow-up data that will enable more advanced versions.

Version 2:

- Growth & developmental tracking

- Pink Card follow-up visits

Version 3

- AI risk prediction for key conditions

- Longitudinal child outcomes

Version 4

- Personalized support & dashboards

- Population-scale validated data

Through this pathway, NeuroLacto.AI can evolve from a screening tool into a national preventive child-health platform. Potential future prediction targets include autism spectrum disorder, developmental delay, feeding disorders, growth faltering, and speech/cognitive delay. The purpose is not to replace physicians, but to support earlier referral, better prioritization, and timely intervention.

What NeuroLacto.AI Has Already Achieved

Version 1, completed

Author:

What Comes Next: Versions 2 to 4

This website uses cookies.